About PTHS Dividend Returns
Pelthos Therapeutics Inc. (PTHS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of PTHS over the past year?
Pelthos Therapeutics Inc. (PTHS) delivered a return of 123.39% over the past year. Since PTHS does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in PTHS be worth today?
A $10,000 investment in Pelthos Therapeutics Inc. one year ago would be worth $22,339 today, representing a gain of $12,339.
Q3Does PTHS pay dividends?
Pelthos Therapeutics Inc. (PTHS) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PTHS, the total return equals the price-only return.
Q4Did PTHS beat the S&P 500?
Yes, Pelthos Therapeutics Inc. (PTHS) outperformed the S&P 500 by 107.94 percentage points over the past year. PTHS delivered a total return of 123.39%, compared to the S&P 500's 15.45%. This 107.94pp alpha means investors in PTHS earned more than a passive S&P 500 index fund.
Q5What is PTHS's worst drawdown?
Pelthos Therapeutics Inc. (PTHS) experienced a maximum drawdown of -47.62% over the past year, declining from its peak on 2025-11-06 to its trough on 2026-02-18. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is PTHS's long-term total return over 10, 20, or 30 years?
Pelthos Therapeutics Inc. (PTHS) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 123.4% (8.4% CAGR) — $10,000 would have grown to $22,339. Over 20 years: 123.4% total return (4.1% CAGR) — $10,000 → $22,339. Over 30 years: 123.4% total return (2.7% CAGR) — $10,000 → $22,339. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was PTHS's best and worst year?
Pelthos Therapeutics Inc.'s best calendar year was 2025 with a total return of 162.7%. Its worst year was 2025 with a total return of 162.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 0.0 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).